Letybo 50iu Botulinum Toxin Type A

Description

Letybo 50 Units Botulinum Toxin Type A: Enhance your patients’ appearance with Letybo’s prescription-strength Botulinum Toxin Type A. Clinically proven to reduce moderate to severe glabellar lines in adults, this powerful treatment will leave your patients feeling confident and rejuvenated.

Ideal patients for Letybo would be adults under the age of 75 with concerns of deep to severe glabellar lines

Key Features

• Shows its effects within two-three days
• Effects can last longer than other leading brands
• Reduced likelihood of uneven results

Mode of Action:

Clostridium botulinum neurotoxin type A blocks the peripheral release of the neurotransmitter acetylcholine at presynaptic cholinergic nerve terminals of neuromuscular junctions by cleaving SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within the nerve endings, thereby leading to denervation of the muscle and a flaccid paralysis.

Contraindications of Letybo:

-Hypersensitivity to the active substance or to any of the excipients.

-Generalised disorders of muscle activity such as myasthenia gravis, Lambert-Eaton syndrome, and amyotrophic lateral sclerosis

-Presence of acute infection or inflammation at the proposed injection sites.

Who Is the Ideal Patient For Letybo?

Ideal patients for Letybo would be adults under the age of 75 with concerns of deep to severe glabellar lines.

Patients who are pregnant or breastfeeding should not use Letybo.

Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.13707.pdf

EMC: https://www.medicines.org.uk/emc/product/13707/smpc